This site is intended for UK Healthcare professionals only

Are you a UK Healthcare professional?

We are unfortunately unable to allow patients to attend CPC

CPC 2022 Programme

Subpage Hero



Evidence Review of Pharmaceutical Public Health in the UK

13 May 2022
Clinical Leadership
Evidence Review of Pharmaceutical Public Health in the UK

Key findings from the UK wide Pharmaceutical Public Health (PPH) evidence review and recommendations

  • By the end of the session delegates will be able to describe the key findings and recommendations from the PPH mixed method review which involved four separate investigations:
  • •Seven rapid evidence reviews on topics relating to the expanded role of pharmacy professionals outside traditional community pharmacy settings.
  • •A call for evidence from key pharmacy stakeholders across UK to identify additional grey literature, relevant policy documents and case studies.
  • •Two surveys, the first sought the views of pharmacy professionals with interest in public health and the second sought the views of public health professionals/specialists. The surveys explored how pharmacy professionals are working in public/population health roles as well as barriers and facilitators.
Dr Diane Ashiru-Oredope, Lead Pharmacist, HCAI, Fungal, AMR, AMU & Sepsis Division - UK Health Security Agency, NHSE&I


Lead Education Partner

  • CPPE
  • Morph


Education Partner

  • BOPA
  • BPNG
  • CMHP
  • Health Education England


Education Partner

  • NHS England and NHS Improvement
  • NHS Digital
  • NHSx
  • PTOC
  • GPHC


Education Partner

  • NPPG
  • PCPA
  • PDA
  • Pharmacist Support
  • RPUK
  • SPS


Education Partner

  • Soar Beyond
  • NHCA
  • PrescQIPP
  • Pharmacy Declares
  • GHP and RPS


Media Partner

  • C&D
  • PDA
  • PrescQIPP
  • Scottish Healthcare Review
  • Welsh Healthcare Review
  • NI Healthcare Review
  • Prescriber


Nominated Charity

  • Pharmacist Support


Newsletter Sign Up